Holowesko Partners Ltd. Merck & Co., Inc. Transaction History

Holowesko Partners Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $4.23 Million - $4.75 Million	-50,000 Reduced 78.74%	13,500 $1.16 Million
Q2 2022 Aug 11, 2022	SELL	$83.49 - $94.64 $6.26 Million - $7.1 Million	-75,000 Reduced 54.15%	63,500 $5.79 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $367,550 - $412,000	5,000 Added 3.75%	138,500 $11.4 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $9.57 Million - $10.5 Million	133,500 New	133,500 $10 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Holowesko Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Holowesko Partners Ltd. with notifications on news.